Dr John Conibear
Consultant Clinical Oncologist
BSc MBBCh MSc MRCP FRCR MD(Res)
Languages spoken: English
Dr John Conibear
Consultant Clinical Oncologist
BSc MBBCh MSc MRCP FRCR MD(Res)
Languages spoken: English
Patient Age Group
AdultsYear qualified
2001Specialties
Clinical oncology, Breast, LungGender
MaleClinical Interests
Dr Conibear specialises in all the non-surgical treatments for both lung and breast cancers. He has expertise in chemotherapy, biological therapy, immunotherapy, radiotherapy, and state of the art radiotherapy techniques. These advanced delivery techniques include deep inspiration breath hold (DIBH) for early breast cancer, Intensity Modulated Radiotherapy (IMRT), Image Guided Radiotherapy (IGRT) and 4D-CT.
Dr Conibear is also trained in using state of the art radiotherapy technologies including the ViewRay MRIdian MRI-guided linac, Accuray Cyberknife and Leksell Icon Gamma Knife. These technologies are used to deliver stereotactic ablative body or brain radiotherapy (SABR / SRS).
Biography
Dr John Conibear graduated from the University Hospital of Wales in 2001 and completed his post-graduate general medical training in The Barts and The London Training rotation in 2006.
Before gaining his substantive post as a consultant clinical oncologist in St. Bartholomew’s Hospital in 2014, he completed a 2-year fellowship with the NCRI Radiotherapy Trials Quality Assurance Group in Mount Vernon Hospital. During his fellowship he conducted research into techniques to improve clinician target outlining during radiotherapy planning and was subsequently awarded a MD(Res) from UCL in 2018.
Dr Conibear is currently deputy medical director of St. Bartholomew’s Hospital and deputy director of Barts Cancer Centre. He is also the lead for chemotherapy and clinical director for thoracic oncology in St. Bartholomew’s Hospital. He is currently the centre lead for the GenesisCare radiotherapy department in the Cromwell Hospital. Dr Conibear is the oncology clinical lead for the National Lung Cancer Audit (NLCA).
Before gaining his substantive post as a consultant clinical oncologist in St. Bartholomew’s Hospital in 2014, he completed a 2-year fellowship with the NCRI Radiotherapy Trials Quality Assurance Group in Mount Vernon Hospital. During his fellowship he conducted research into techniques to improve clinician target outlining during radiotherapy planning and was subsequently awarded a MD(Res) from UCL in 2018.
Dr Conibear is currently deputy medical director of St. Bartholomew’s Hospital and deputy director of Barts Cancer Centre. He is also the lead for chemotherapy and clinical director for thoracic oncology in St. Bartholomew’s Hospital. He is currently the centre lead for the GenesisCare radiotherapy department in the Cromwell Hospital. Dr Conibear is the oncology clinical lead for the National Lung Cancer Audit (NLCA).
NHS Base (trust)
Barts Health NHS Trust
Professional memberships
American Society of Clinical Oncology (ASCO), British Medical Association (BMA), General Medical Council (GMC), International Association for the Study of Lung Cancer (IASLC), Royal College of Physicians, Royal College of Radiologists (RCR)
